x
Filter:
Filters applied
- Pathway of the Month
- Drabkin, Harry ARemove Drabkin, Harry A filter
- Journal of Thoracic OncologyRemove Journal of Thoracic Oncology filter
Pathway of the Month
1 Results
- Pathway of the MonthOpen Archive
Semaphorins in Lung Cancer
Journal of Thoracic OncologyVol. 1Issue 3p203–204Published in issue: March, 2006- Jonathan Clarhaut
- Joëlle Roche
- Harry A. Drabkin
Cited in Scopus: 2The secreted class 3 semaphorins, which include SEMA3F, a tumor-suppressor gene in lung cancer, were initially identified as molecules involved in the repulsion of developing nerve growth cones. These molecules are part of a larger family that includes transmembrane and membrane-associated proteins, some of which are expressed widely and implicated in other functions such as development and immune response.1 SEMA3B and SEMA3F are both encoded in 3p21.3,2–4 a region of frequent loss of heterozygosity in lung cancer,5 which initially suggested that one or both of these genes might have tumor-suppressor activity.